Table 3.
Hindlimbs | Groups | N (limbs) | Mean (ms) | SD | Min | Max | χ2 | DF | p |
---|---|---|---|---|---|---|---|---|---|
Latency | CG | 16 | 27.83 | 8.77 | 15.80 | 40.30 | 6.626 | 3 | 0.85 |
MG | 16 | 23.71 | 3.74 | 16.30 | 29.10 | ||||
G-CSF | 16 | 22.36 | 7.30 | 12.50 | 34.20 | ||||
G-CSF-M | 16 | 21.30 | 8.20 | 12.40 | 40.30 | ||||
Amplitude | CG | 16 | 26.86 | 14.78 | 6.00 | 50.10 | 6.898 | 3 | 0.075 |
MG | 16 | 43.98 | 65.22 | 4.70 | 276.80 | ||||
G-CSF | 16 | 64.71 | 92.85 | 10.90 | 312.10 | ||||
G-CSF-M | 16 | 97.43 | 115.58 | 4.70 | 483.00 |
CG = control group; MG = methylprednisolone group; G-CSF = granulocyte colony-stimulating factor group and G-CSF-M = group receiving G-CSF and methylprednisolone.